A Randomized, Double-blind, Double Dummy, Parallel Group, Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (KALOS).

Project: Research

Project Details

StatusActive
Effective start/end date15/01/21 → 31/12/24

Keywords

  • Respiratory medicine
  • Asthma
  • Clinical trial